These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7950781)

  • 21. [Psychophysiological approaches to assessing patients with painful and painless forms of ischemic heart disease].
    Lipovetskii BM; Reznikova TN; Il'ina GN; Petukhova NV; Stoianov AM
    Ter Arkh; 1995; 67(12):8-11. PubMed ID: 8820044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nitrates in therapy of effort angina in hypotensive patients].
    Idrisova EM; Borovkova NV; Kladieva EA; Chernov VI; Demochko AV; Shishkina AA; Vorob'eva EV; Karpov RS
    Klin Med (Mosk); 2003; 81(11):54-8. PubMed ID: 14689713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Increased myocardial resistance to ischemia in a chronic model of stenocardia].
    Pozin VM; Skuratovskaia SG; Pocheptsova GA
    Biull Eksp Biol Med; 1993 Sep; 116(9):235-8. PubMed ID: 7509646
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of a compound preparation pumpan on exercise tolerance and clinical course of ischemic heart disease].
    Krasnitskiĭ VB; Aronov DM; Zhidko NI
    Ter Arkh; 2003; 75(8):17-21. PubMed ID: 14520844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of diuretic therapy on exercise capacity in patients with chronic angina and preserved left ventricular function.
    Finimundi HC; Caramori PA; Parker JD
    J Cardiovasc Pharmacol; 2007 May; 49(5):275-9. PubMed ID: 17513945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
    Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The optimization of the hemodynamic characteristics in patients with ischemic heart disease and circulatory failure by using a substrate-coenzyme complex].
    Vizir AD; Dunaev VV; Berezin AE; Kraĭdashenko OV
    Lik Sprava; 1997; (5):53-6. PubMed ID: 9491697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment with nitrate depot preparations and calcium antagonists].
    Schlup P
    Schweiz Med Wochenschr; 1981 Mar; 111(13):449-54. PubMed ID: 7233123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiointervalography in the practice of experimental and clinical pharmacology].
    Arushanian EB
    Eksp Klin Farmakol; 1995; 58(5):74-8. PubMed ID: 8704599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controversies in cardiovascular care: silent myocardial ischemia.
    Hollenberg NK
    Complicat Card Patient; 1987; 1(2):24-30. PubMed ID: 11539715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dilzem-retard efficiency in patients with ischemic heart disease and heart failure].
    Gadzhiev AN
    Klin Med (Mosk); 2002; 80(6):45-8. PubMed ID: 12138803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of amlodipine and lacidipine on heart rate variability in hypertensive patients with stable angina pectoris and isolated left ventricular diastolic dysfunction.
    Zaliūnas R; Brazdzionyte J; Zabiela V; Jurkevicius R
    Int J Cardiol; 2005 Jun; 101(3):347-53. PubMed ID: 15907400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The influence of a long-acting formulation of propranolol on the circadian rhythm of heart rate in elderly patients with essential hypertension].
    Shimamoto Y; Nakamura H; Shimamoto H; Sakata S
    Kokyu To Junkan; 1988 Nov; 36(11):1205-10. PubMed ID: 3247537
    [No Abstract]   [Full Text] [Related]  

  • 36. [An amino acid metabolic complex in optimizing the cardiac hemodynamic characteristics of patients with ischemic heart disease].
    Berezin AE; Fushteĭ IM; Kraĭdashenko OV
    Lik Sprava; 1998 Dec; (8):94-6. PubMed ID: 10204359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronobiological aspects of ischemic heart disease.
    Aslanian NL
    Prog Clin Biol Res; 1990; 341B():583-92. PubMed ID: 2217347
    [No Abstract]   [Full Text] [Related]  

  • 38. [The clinical pharmacology of antianginal agents].
    Metelitsa VI; Martsevich SIu; Kokurina EV; Bochkareva EV; Kozyreva MP; Kutishenko NP; Rumiantsev DO; Blagodatskikh SV; Vodop'ianova RS; Kukushkin SK
    Eksp Klin Farmakol; 1995; 58(2):3-7. PubMed ID: 7773085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in the blood content of some vitamins in patients with ischemic heart disease].
    Boev SS
    Lik Sprava; 2003; (5-6):26-7. PubMed ID: 14618796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitrates in silent ischemia.
    Purcell H; Mulcahy D; Fox K
    Cardiovasc Drugs Ther; 1994 Oct; 8(5):727-34. PubMed ID: 7873469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.